InvoX is a leading developer, manufacturer and supplier of complex respiratory drug-device combination and medicinal products to patients. Harnessing next-generation technology and development platforms, we focus on developing and commercializing novel therapies to bring transformative medicines to patients through global partnerships, enhancing health and quality of life.

invoX’s next generation device platform Softhaler® is a soft mist inhaler (SMI) engineered to deliver active pharmaceutical ingredients (APIs), new chemical entities (NCEs), and biological molecules directly to the lungs. Using advanced, propellant-free technology, the device administers liquid-based formulations as a fine mist, optimizing drug delivery with greater precision and efficacy compared to traditional inhalers.